# Rani Therapeutics Holdings, Inc. (RANI) — capital_raise/public_offering [announced]
Source: sec.gov · situation sit_63270ad5b545c2db79d2 · public 2309979340157166349 · retrieved 2026-08-19T11:34:47.415Z

## Overview
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs using its proprietary RaniPill® Capsule platform technology.

Rani Therapeutics Holdings, Inc. completed a $20.0 million registered direct offering in May 2026, with the offering led by a sovereign wealth fund along with other new and existing healthcare-focused funds. The offering strengthened the company's cash position.

## Terms
- Counterparty: Sovereign wealth fund and healthcare-focused funds · Deal value: $20.0M · Consideration: stock

## Key dates
- Announced 2026-08-13

## Timeline
- 2026-08-13 · 8-K (0001193125-26-349197): 8-K - Rani Therapeutics Holdings, Inc. — *Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs using its proprietary RaniPill® Capsule platform technology.* Rani Therapeutics Holdings, Inc. completed a $20.0 million registered direct offering in May 2026, with the offering led by a sovereign wealth fund along with other new and existing healthcare-focused funds. The offering strengthened the company's cash position.
  https://www.sec.gov/Archives/edgar/data/1856725/0001193125-26-349197.txt

## Citations
- 0001193125-26-349197 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526349197